IRIS UniCatt

Pierconti, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.260
EU - Europa 4.256
AS - Asia 3.976
SA - Sud America 846
Continente sconosciuto - Info sul continente non disponibili 228
AF - Africa 117
OC - Oceania 13
AN - Antartide 1
Totale 16.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.043
SG - Singapore 1.729
IT - Italia 1.301
CN - Cina 874
DE - Germania 696
SE - Svezia 693
BR - Brasile 669
VN - Vietnam 403
FR - Francia 319
PL - Polonia 310
IN - India 184
GB - Regno Unito 179
UA - Ucraina 179
BD - Bangladesh 150
IE - Irlanda 149
ID - Indonesia 120
JP - Giappone 120
CA - Canada 105
FI - Finlandia 93
HK - Hong Kong 79
RU - Federazione Russa 79
NL - Olanda 77
TR - Turchia 65
AR - Argentina 53
MX - Messico 44
BE - Belgio 35
IQ - Iraq 35
CO - Colombia 34
ES - Italia 32
ZA - Sudafrica 32
EC - Ecuador 31
AT - Austria 27
KR - Corea 27
PK - Pakistan 22
VE - Venezuela 22
CI - Costa d'Avorio 18
SA - Arabia Saudita 18
IR - Iran 17
MA - Marocco 17
UZ - Uzbekistan 16
CR - Costa Rica 15
JO - Giordania 14
PH - Filippine 14
CH - Svizzera 13
JM - Giamaica 13
LT - Lituania 11
NP - Nepal 11
AZ - Azerbaigian 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
UY - Uruguay 9
AU - Australia 8
KE - Kenya 8
NI - Nicaragua 8
OM - Oman 8
CL - Cile 7
DZ - Algeria 7
EE - Estonia 7
EG - Egitto 7
LV - Lettonia 7
TT - Trinidad e Tobago 7
LB - Libano 6
NO - Norvegia 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
LK - Sri Lanka 5
MY - Malesia 5
PT - Portogallo 5
SN - Senegal 5
AL - Albania 4
BG - Bulgaria 4
DK - Danimarca 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
MD - Moldavia 4
PR - Porto Rico 4
RO - Romania 4
CZ - Repubblica Ceca 3
EU - Europa 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
MM - Myanmar 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
TH - Thailandia 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
GE - Georgia 2
Totale 16.444
Salva come PNG Salva come JPEG
Città #
Singapore 987
Ashburn 769
San Jose 695
Chandler 571
Warsaw 289
Beijing 187
Rome 169
Milan 164
Los Angeles 156
Ho Chi Minh City 154
New York 153
Dublin 149
Council Bluffs 135
Ann Arbor 127
Jacksonville 119
Fairfield 118
The Dalles 113
San Mateo 112
Wilmington 108
Lauterbourg 103
Jakarta 102
Chicago 97
Hanoi 97
Seattle 96
Nanjing 94
Frankfurt am Main 90
Tokyo 85
Houston 79
Cambridge 69
São Paulo 69
Hong Kong 68
Woodbridge 66
Munich 64
Hefei 62
Boston 61
Dearborn 59
Hyderabad 58
Moscow 58
Santa Clara 58
Dallas 57
Princeton 53
Atlanta 43
Helsinki 43
Redmond 43
Izmir 42
Bremen 40
Orem 37
Nanchang 36
Marseille 34
Phoenix 33
Denver 32
Buffalo 31
Cattolica 31
Naples 31
Stockholm 31
Toronto 30
Bologna 29
Brussels 29
Verona 29
Kadoma 28
Lawrence 28
Montreal 26
Shanghai 25
Nürnberg 24
Seoul 24
Florence 23
Bari 22
Belo Horizonte 22
Brasília 21
Brooklyn 21
Johannesburg 21
Kent 21
London 21
Redwood City 21
Amsterdam 19
Miami 19
Shenyang 19
Abidjan 18
Da Nang 18
Enterprise 18
Mountain View 18
Turin 18
Boardman 17
Dhaka 17
Düsseldorf 17
Kunming 17
Nuremberg 17
Palermo 17
Rio de Janeiro 17
Vienna 17
Catania 16
Chennai 16
Hangzhou 16
Manchester 16
Memphis 16
Paris 16
Tianjin 16
Guangzhou 15
Mumbai 15
Poplar 15
Totale 8.332
Salva come PNG Salva come JPEG
Nome #
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 954
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 432
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 337
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. 319
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 296
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 285
Metabolic reprogramming by malat1 depletion in prostate cancer 279
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 275
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 265
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 264
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 256
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 223
Incidental finding of right renal venous aneurysm in a patient with symptomatic ipsilateral renal carcinoma: a case report 202
A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience 198
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 196
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 189
Bromodomain and Extra-Terminal Family Proteins BRD2, BRD3, and BRD4 Contribute to H19-Dependent Transcriptional Regulation of Cell Adhesion Molecules, Modulating Metastatic Dissemination Program in Prostate Cancer 187
MECKEL'S DIVERTICULUM FINDINGS ON TC-99 RED BLOOD SCINTIGRAPHY IN A BLEEDING LEUKEMIC PATIENT CONFIRMED BY TC-99 PERTENECHTATE SCINTIGRAPHY 185
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 183
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 182
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 179
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 174
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 174
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 174
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 174
Bladder and prostate metastasis from small cell lung cancer: a rare entity 172
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 166
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 163
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 161
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 161
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. 160
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 159
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 156
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 152
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 151
Methylation study of the Paris system for reporting urinary (TPS) categories 151
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 150
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 148
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 148
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 147
Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications 147
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 146
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 145
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 144
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 143
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 143
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 142
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 142
Olfactory receptors in semen and in the male tract: From proteome to proteins 139
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 138
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 138
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 136
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 135
Biomarkers of response to advanced prostate cancer therapy 135
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 133
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 133
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 132
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 132
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 131
Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology 131
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 129
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 128
p53 expression in cytology samples may represent a marker of early-stage cancer 126
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 125
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 123
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 122
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 120
Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy 118
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 117
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 116
Giant spermatic cord liposarcoma 115
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 115
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 115
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 115
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 113
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 111
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 110
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 110
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 110
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 109
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 108
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 108
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 108
Proteomics for the identification of biomarkers in testicular cancer–review 108
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 104
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. 103
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 103
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 102
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 100
Mesenchymal differentiation of glioblastoma stem cells 97
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 96
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 96
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 96
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 95
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 95
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 95
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 90
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B-cell lymphoma: A case report 89
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 88
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 87
Totale 16.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022718 0 0 0 80 70 28 38 125 41 57 131 148
2022/20231.769 249 232 139 261 92 210 84 130 179 69 83 41
2023/20241.194 79 227 62 75 89 158 93 61 24 84 104 138
2024/20252.177 70 61 196 94 175 128 75 101 243 247 448 339
2025/20265.652 743 187 313 690 969 285 1.005 296 377 362 253 172
2026/20272.373 257 1.221 496 399 0 0 0 0 0 0 0 0
Totale 16.697